Therapeutic Targeting of Apoptosis‐Driven Inflammation in Rheumatoid Arthritis: A Biochemical and Molecular Modeling Approach Using Plant‐Derived Compounds
International Journal of Rheumatic Diseases · 2025-09 · 28 (9)
DOI: 10.1111/1756-185x.70423 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Rheumatic Diseases, online erschienen am 24.09.2025. Verfasst von Zafer Saad Alshehri. Beteiligte Einrichtung: Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Shaqra University, Shaqra, Kingdom of Saudi Arabia. Hauptthemen laut MEDLINE: Apoptosis, Arthritis, Rheumatoid, Phytochemicals, Anti-Inflammatory Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent synovial inflammation, joint destruction, and resistance to apoptosis in fibroblast‐like synoviocytes and immune cells. This apoptotic imbalance promotes unchecked cell proliferation and invasive pannus formation, contributing to disease progression. Current therapies predominantly target inflammatory pathways, often overlooking the crucial role of restoring apoptosis. Our study explores the potential of plant‐derived phytochemicals to modulate both inflammation and apoptosis in RA. Using an integrated computational approach, 12 bioactive compounds were evaluated for their interactions with key apoptosis‐associated proteins MMP9, SRC, and EGFR, which are known to influence cell survival, matrix degradation, and invasive behavior in RA. Molecular docking revealed that quercetin, apigenin, resveratrol, and naringenin exhibit strong binding affinities with MMP9, SRC, and EGFR. These interactions were further supported by stable molecular dynamics (MD) simulations, indicating favorable binding stability and structural compatibility. The modulation of these targets suggests a dual therapeutic effect—suppressing inflammation and restoring apoptotic signaling, thus potentially reversing pathological synovial hyperplasia. This study underscores the importance of targeting apoptosis‐related proteins in RA and highlights plant‐derived compounds as promising candidates for multi‐target therapeutic development. By addressing both inflammatory and apoptotic dysregulation, these natural agents may offer a safer and more effective strategy for RA management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Shaqra University, Shaqra, Kingdom of Saudi Arabia.
ORCID-Profile: Zafer Saad Alshehri
Zitieren
APA
Alshehri, Z. S. (2025). Therapeutic Targeting of Apoptosis‐Driven Inflammation in Rheumatoid Arthritis: A Biochemical and Molecular Modeling Approach Using Plant‐Derived Compounds. International Journal of Rheumatic Diseases, 28(9). https://doi.org/10.1111/1756-185x.70423
Vancouver
Alshehri ZS. Therapeutic Targeting of Apoptosis‐Driven Inflammation in Rheumatoid Arthritis: A Biochemical and Molecular Modeling Approach Using Plant‐Derived Compounds. International Journal of Rheumatic Diseases. 2025;28(9). doi:10.1111/1756-185x.70423
BibTeX
@article{Alshehri2025,
author = {Alshehri, Zafer Saad},
title = {Therapeutic Targeting of Apoptosis‐Driven Inflammation in Rheumatoid Arthritis: A Biochemical and Molecular Modeling Approach Using Plant‐Derived Compounds},
journal = {International Journal of Rheumatic Diseases},
year = {2025},
volume = {28},
number = {9},
doi = {10.1111/1756-185x.70423}
}
EUVIMED